Typology - ISS-G20 Laboratorium Repository

Plan, prepare, act: Government of Canada launches first National Adaptation Strategy - Canada.ca
  Climate change is affecting the safety, health, and quality of life of people across Canada. Ever...

WHO Policy Brief: Gatherings in the context of COVID-19, 19 January 2023
Gatherings are events characterized by the concentration of people at a specific location for a spec...

Coronavirus Test Device Approvals (CTDA): statutory review of process
The Coronavirus Test Device Approvals (CTDA) requires antigen and molecular COVID-19 tests to unde...

Statutory review of the Coronavirus Test Device Approvals (CTDA) process
The requirements of the Coronavirus Test Device Approvals (CTDA) process are set out in the Medical ...

World Health Organization WHO emergency preparedness mandate
The foundation for WHO’s work in the area of emergency preparedness and response is laid down in Art...

Severe Acute Respiratory Infection (SARI) surveillance in secondary care - Respiratory surveillance - Respiratory infections - Conditions and diseases - Our areas of work - Public Health Scotland
Overview of the programme Respiratory surveillance activities in hospitals (secondary care) inclu...

Yemen: National action plan to combat antimicrobial resistance 2022-2026
Yemen: National action plan to combat antimicrobial resistance 2022-2026 2022-2026World Health Organ...

WHO Malaria Policy Advisory Group (MPAG) meeting (October 2022)
On 11–13 October 2022, the WHO Malaria Policy Advisory Group (MPAG) convened virtually to review upd...

NOIDs causative agents: week 46 (week ending 20 November 2022)
Statutory notifications of causative agents, grouped by root organism Totals for the current week c...

COVID-19 Scientific and Public Health Policy Update (28 September 2022) – Africa CDC
This bi-weekly brief details the latest developments in scientific knowledge and public health polic...

COVID-19 Scientific and Public Health Policy Update (14 September 2022) – Africa CDC
This bi-weekly brief details the latest developments in scientific knowledge and public health polic...

WHO policy brief: Reaching COVID-19 vaccination targets, 14 September 2022
Key points  The World Health Organization’s most recent Global Covid-19 Vaccination Strategy...

WHO policy brief: Maintaining infection prevention and control measures for COVID-19 in health care facilities, 14 September 2022
Key points  Health care facilities remain a high-risk SARS-CoV-2 transmission setting becaus...

WHO policy brief: Building trust through risk communication and community engagement, 14 September 2022
Key points  Credible, trusted, relevant, timely, accessible and actionable heath information...

WHO policy brief: COVID-19 infodemic management, 14 September 2022
Key points  Train health workers, who are often the most trusted source of health informatio...

WHO policy brief: COVID-19 testing, 14 September 2022
Key points  • It remains critical for national programmes to continue to offer testing for COV...

WHO policy brief: Clinical management of COVID-19, 14 September 2022
Key points  • Establishing and sustaining clear pathways to clinical care is a critical elemen...

Regulatory approval of Pfizer/BioNTech bivalent Original/Omicron booster vaccine - GOV.UK
Comirnaty Original/Omicron BA.1 is a vaccine used for preventing COVID-19 caused by SARS‑CoV-2. It ...

Regular asymptomatic testing paused in additional settings - GOV.UK
Routine asymptomatic testing will be paused across remaining settings, including hospitals and car...

COVID-19 Scientific and Public Health Policy Update – (03 August 2022) – Africa CDC
This bi-weekly brief details the latest developments in scientific knowledge and public health polic...